Testosterone

Especificaciones

58-22-0Número CAS

200-370-5Número CE

(8R,9S,10R,13S,14S,17S)-17-hydroxy-10,13-dimethyl-1,2,6,7,8,9,11,12,14,15,16,17-dodecahydrocyclopenta[a]phenanthren-3-oneNombre IUPAC

C19H28O2Fórmula química

288.4 g/molPeso molecular

testosterone; 58-22-0; Virosterone; Homosterone; Mertestate; Testim; Androderm; Testosteron; Androlin; Sustanon; Testiculosterone; Orquisteron; Primoteston; Testosteroid; Andrusol; Homosteron; Primotest; Sustanone; Testobase; Testoderm; Testrone; Testryl; Teslen; Synandrol F; Andronaq; Neotestis; Testandrone; Testogel; Testopropon; Relibra; Cristerona T; Testoviron Schering; Testoviron T; Geno-cristaux gremy; Andropatch; trans-Testosterone; 17beta-Hydroxyandrost-4-en-3-one; Testostosterone; Sustason 250; Percutacrine androgenique; Intrinsa; Testolin; Testosterona; Striant; Testoject-50; Testoderm Tts; Testosterone hydrate; Testro AQ; Malestrone (amps); Testosteronum; Livensa; Vogelxo; delta4-Androsten-17beta-ol-3-one; Fortesta; Axiron; Androst-4-en-17beta-ol-3-one; 17beta-Hydroxy-4-androsten-3-one; Testosterone ciii; 17beta-Hydroxyandrost-4-ene-3-one; 17-beta-Hydroxyandrost-4-en-3-one; Androgel 1%; Bio-T-Gel; ANDROLAN; ANDROID-T; delta(sup 4)-Androsten-17(beta)-ol-3-one; 17-Hydroxy-(17-beta)-androst-4-en-3-one; 4-Androsten-17beta-ol-3-one; 17-beta-Hydroxy-delta(sup 4)-androsten-3-one; DTXSID8022371; Androst-4-en-3-one, 17-beta-hydroxy-; Androst-4-en-3-one, 17-hydroxy-, (17beta)-; 3XMK78S47O; (8R,9S,10R,13S,14S,17S)-17-hydroxy-10,13-dimethyl-1,2,6,7,8,9,11,12,14,15,16,17-dodecahydrocyclopenta[a]phenanthren-3-one; CHEBI:17347; (17beta)-17-Hydroxyandrost-4-en-3-one; NSC-9700; D4-Androsten-17b-ol-3-one; DTXCID302371; NSC9700; Testopatch; Testopel; Tostran; testosterone,; Striant sr; Testostroval-PA; 17 beta Hydroxy 4 Androsten 3 one; Testosterone,USP; 8 Isotestosterone; Natesto nasal gel; (8R,9S,10R,13S,14S,17S)-17-hydroxy-10,13-dimethyl-1,2,6,7,8,9,11,12,14,15,16,17-dodecahydrocyclopenta(a)phenanthren-3-one; Testim 1%; RefChem:6503; Testo-100; Testosterone Gel, 1%; Therapeutic Testosterone; 17-beta-Hydroxy-4-Androsten-3-one; 17 beta Hydroxy 8 alpha 4 Androsten 3 one; 17-beta-Hydroxy-8 alpha-4-Androsten-3-one; (1S,2R,10R,11S,14S,15S)-14-hydroxy-2,15-dimethyltetracyclo(8.7.0.02,7.011,15)heptadec-6-en-5-one; 200-370-5; Testostroval; Oreton; AndroGel; Perandren; Malerone; Testoviron; Cristerone T; Oreton-F; LibiGel; Andro 100; beta testosterone; Malogen, aquaspension injection; Testosteronum [INN-Latin]; Testosterona [INN-Spanish]; Natesto; Neo-Hombreol F; 7-beta-Hydroxyandrost-4-en-3-one; COL 1621; 17-Hydroxy-(17beta)-androst-4-en-3-one; 17beta-Hydroxy-delta(sup4)-androsten-3-one; (+)-testosterone; Androst-4-en-3-one, 17beta-hydroxy-; Neo-testis; Testopel Pellets; CDB 111C; (8R,9S,10R,13S,14S,17S)-17-Hydroxy-10,13-dimethyl-6,7,8,9,10,11,12,13,14,15,16,17-dodecahydro-1H-cyclopenta[a]phenanthren-3(2H)-one; Halotensin; Nasobol; Tefina; Androst-4-en-3-one, 17-hydroxy-, (17.beta.)-; CompleoTRT; CP 601B; Androderm (TN); 17.beta.-Testosterone; Androgel (TN); SMR000058344; Testosterone (1.0mg/mL in Acetonitrile); CCRIS 574; Striant (TN); AA 2500; Testim (TN); Androgel 1.62%; HSDB 3398; NSC 9700; EINECS 200-370-5; Testosterone (JAN/USP); Androst-4-en-3-on-17B-ol; CHEMBL386630; component of Duogen (Salt/Mix); component of Tostrex (Salt/Mix); component of Di-Met (Salt/Mix); UNII-3XMK78S47O; component of Intrinsa (Salt/Mix); Epitestosteron; Lumitestosteron; 4-Androsten-17.beta.-ol-3-one; 4-Androsten-3-one-17.beta.-ol; Tostrelle; Tostrex; Viatrel; Atmos; component of Di-Genik (Salt/Mix); 4-Androsten-3-one, 17b-hydroxy-; Testosterone [USP:INN:BAN]; 9b-testosterone; Andropatch;; component of Mal-O-Fem (Salt/Mix); 4-androstene-17beta-ol-3-one; 17b-hydroxy-4-androsten-3-one; delta4-androsten-17b-ol-3-one; LPCN 1021; Testosterone CRS; Testosterone, 1; 3kdm; Androst-4-en-3-one, 17-hydroxy-, (17b)-; 17b-Testosterone; 17-.beta.-Hydroxyandrost-4-en-3-one; NCGC00091018-01; 8-iso-testosterone; Androst-4-en-3-one, 17-hydroxy-, (17-beta)-; (+-)-testosterone; Axiron (TN); CMC_13449; 13-iso-testosterone; mpp10; TESTSTERONE; 9b,10a-testosterone; 17.beta.-Hydroxy-.DELTA.4-androsten-3-one; 17-Hydroxyandrost-4-en-3-one, (17.beta.)-; (+-)-retrotestosterone; Testosterone, >=98%; TESTOSTERONE [MI]; TESTOSTERONE [INN]; TESTOSTERONE [JAN]; Epitope ID:135865; EC 200-370-5; TESTOSTERONE [HSDB]; (+-)-8-iso-testosterone; SCHEMBL8452; 4-Androsten-17beta-ol-one; TESTOSTERONE [VANDF]; TESTOSTERONE [MART.]; 4-Androsten-3-one-17b-ol; MLS000563091; MLS001032098; MLS001306401; MLS001424262; MLS002174283; BIDD:ER0555; TESTOSTERONE [WHO-DD]; US9682960, Testosterone; Androst-4-en-17b-ol-3-one; BDBM8885; GTPL2858; SCHEMBL5433252; SCHEMBL5433257; Androst-4-ene-17b-ol-3-one; TESTOSTERONE [EMA EPAR]; SCHEMBL11036482; 17-hydroxy-D4-androsten-3-one; 17-hydroxy-androst-4-en-3-one; 17beta-hydroxy-4-androsten-3one; MSK2220; TESTOSTERONE [GREEN BOOK]; Testosterone, cell culture tested; 17b-Hydroxy-androst-4-en-3-on; 17b-Hydroxy-D4-androsten-3-one; 17b-Hydroxyandrost-4-ene-3-one; 1i37; Testosterone, 1mg/ml in Methanol; 17a-hydroxy-androst-4-en-3-one; 17b-hydroxy-androst-4-en-3-one; HMS2052N11; HMS2272B03; HMS2272P03; TESTOSTERONE [EP IMPURITY]; TESTOSTERONE [ORANGE BOOK]; TESTOSTERONE [EP MONOGRAPH]; 17-Hydroxy-10,13-dimethyl-1,2,6,7,8,9,10,11,12,13,14,15,16,17-tetradecahydro-cyclopenta[a]phenanthren-3-one; TESTOSTERONE [USP MONOGRAPH]; Tox21_200689; HY-15554A; LMST02020002; MSK2220-100A; 17b-hydroxy-8a-androst-4-en-3-one; rac-17b-hydroxy-androst-4-en-3-one; AKOS015894897; MSK2220-1000A; 17a-hydroxy-13a-androst-4-en-3-one; 17a-hydroxy-14b-androst-4-en-3-one; 17b-hydroxy-13a-androst-4-en-3-one; CCG-101189; CS-1415; DB00624; Human Serum - Testosterone, low level; NC00439; CAS-58-22-0; Human Serum - Testosterone, high level; Testosterone (1 mg/mL in Acetonitrile); Testosterone 1.0 mg/ml in Acetonitrile; 17b-hydroxy-(8a)-androst-4-en-3-one; 17b-hydroxy-(9b)-androst-4-en-3-one; NCGC00091018-04; NCGC00258243-01; (17b)-17-hydroxy-androst-4-en-3-one; 17a-hydroxy-(13a)-androst-4-en-3-one; 17b-hydroxy-(10a)-androst-4-en-3-one; 17b-hydroxy-(13a)-androst-4-en-3-one; AC-14899; CPD000058344; FH156772; SMR001261453; Testosterone, purum, >=99.0% (HPLC); Testosterone 100 microg/mL in Acetonitrile; NS00067928; rac-17b-hydroxy-(13a)androst-4-en-3-one; rac-17b-hydroxy-(8a)-androst-4-en-3-one; Testosterone(Discontinued,See C4X-132633); 17b-hydroxy-(8a,10a)-androst-4-en-3-one; 17b-hydroxy-(9b,10a)-androst-4-en-3-one; BIM-0061761.0001; C00535; D00075; rac-17b-hydroxy-(9b,10a)androst-4-en-3-one; S00309; AB00973630-03; Testosterone Solution in Acetonitrile, 100ug/mL; Testosterone, VETRANAL(TM), analytical standard; Androst-4-en-3-one, 17-hydroxy, (17.beta.)-; Testosterone Solution in Acetonitrile, 1000ug/mL; Q1318776; B5DEE83F-632B-48A1-A0ED-A51E7F13DF2E; TESTOSTERONE ENANTATE IMPURITY D [EP IMPURITY]; TESTOSTERONE PROPIONATE IMPURITY C [EP IMPURITY]; Testosterone Working Standard (Secondary Reference Standard); Testosterone, European Pharmacopoeia (EP) Reference Standard; (8alpha,10alpha,13alpha,14beta,17alpha)-17-hydroxyandrost-4-en-3-one; Testosterone; 4-Androsten-17?-ol-3-one; 17?-Hydroxy-4-androsten-3-one; Testosterone for system suitability, European Pharmacopoeia (EP) Reference Standard; (1S,2R,10R,11S,14S,15S)-14-hydroxy-2,15-dimethyltetracyclo[8.7.0.0^{2,7}.0^{11,15}]heptadec-6-en-5-one; 1050678-68-6Sinónimos